Coleman Mark sold AXSM
February 26, 2026 · Form 4 insider transaction
Coleman Mark sold 25,000 shares of Axsome Therapeutics, Inc. at $161.11 per share, a transaction worth $4.03M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
25,000
Price
$161.11
Total value
$4.03M
InsiderColeman Mark
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after47,140
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the sale of underlying shares of previously exercised stock options.; Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $160.33 and $162.26.